A liposomal formulation able to incorporate a high content of Paclitaxel and exert promising anticancer effect
about
Efficient drug delivery of Paclitaxel glycoside: a novel solubility gradient encapsulation into liposomes coupled with immunoliposomes preparationNanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye.Application of liposomes in drug development--focus on gastroenterological targets.Nanoparticle albumin bound Paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time?A platelet-mimetic paradigm for metastasis-targeted nanomedicine platformsDevelopment of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation.Assembly and targeting of liposomal nanoparticles encapsulating quantum dots.Lipid composition has significant effect on targeted drug delivery properties of NGR-modified liposomes.Liposomal formulation for co-delivery of paclitaxel and lapatinib, preparation, characterization and optimization.Piloting Your Nanovehicle to Overcome Biological Barriers.Immunogenicity of antigen-conjugated biodegradable polydiacetylene liposomes administered mucosally.Nanoformulation of paclitaxel to enhance cancer therapy.Synthetic nanovaccines for immunotherapy.Improving oral bioavailability and pharmacokinetics of liposomal metformin by glycerolphosphate-chitosan microcomplexation.Practical Liposomal Formulation for Taxanes with Polyethoxylated Castor Oil and Ethanol with Complete Encapsulation Efficiency and High Loading Efficiency.Distinct solubility and cytotoxicity regimes of paclitaxel-loaded cationic liposomes at low and high drug content revealed by kinetic phase behavior and cancer cell viability studies.Ethanol-based proliposome delivery systems of paclitaxel for in vitro application against brain cancer cells.
P2860
Q28543361-C4074A7D-8785-44DB-ACBF-6E3F2C91EC1DQ35679871-CCE44023-8E61-4BB0-B444-075ADE8C4007Q36758275-7E83793B-E8A5-4E04-B083-FECB03BFBF82Q36860835-868DFF3D-AB00-4C1A-B700-8C822AE82C02Q36949458-2BDBBA70-0303-403B-8EC7-15B404B52132Q37248679-86364E2E-7F9D-4B67-88CE-E4465C465F39Q38257108-849A87E5-0A66-49D8-A19E-92DF1CF4A682Q38835070-DC6376D6-7AC8-4C10-8724-0534F6265AB6Q38844243-34E2E9EB-C675-41CF-A31A-52234F8F0EFEQ39114840-3AE25D75-49FF-4404-9C70-68E6499439BDQ39280954-9E4B5D23-A6EB-4777-AB05-919303CD38C0Q39353078-B1829AA0-C4FA-4CDF-8895-14DA415E749DQ40280801-C675008D-2505-4377-97F9-9F5F318CE9D7Q41125054-DC81F46F-4CC1-4122-BBDA-A012ABCF623DQ45338727-3E502666-29A1-4E6C-95A4-307E4F11E35CQ45932069-5E89763A-F812-4CFA-A053-BBE6590AD23DQ48433803-C7AB0B3D-24EE-48E1-A134-4A06CE1FC91A
P2860
A liposomal formulation able to incorporate a high content of Paclitaxel and exert promising anticancer effect
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A liposomal formulation able t ...... rt promising anticancer effect
@ast
A liposomal formulation able t ...... rt promising anticancer effect
@en
A liposomal formulation able t ...... rt promising anticancer effect
@nl
type
label
A liposomal formulation able t ...... rt promising anticancer effect
@ast
A liposomal formulation able t ...... rt promising anticancer effect
@en
A liposomal formulation able t ...... rt promising anticancer effect
@nl
prefLabel
A liposomal formulation able t ...... rt promising anticancer effect
@ast
A liposomal formulation able t ...... rt promising anticancer effect
@en
A liposomal formulation able t ...... rt promising anticancer effect
@nl
P2093
P2860
P356
P1476
A liposomal formulation able t ...... rt promising anticancer effect
@en
P2093
Ae-June Wang
Chih-Wan Tsao
Hsiang-Fa Liang
Wu-Chou Su
P2860
P304
P356
10.1155/2011/629234
P577
2010-10-11T00:00:00Z